Home

Latest News

12345678910
The Analyst Verdict: IonQ In The Eyes Of 9 Expertsbenzinga.com
Via Benzinga · August 27, 2025
P/E Ratio Insights for Caterpillarbenzinga.com
Via Benzinga · August 27, 2025
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · August 27, 2025
Williams-Sonoma Q2 Results Prove Its Buy-and-Hold Qualitymarketbeat.com
Williams-Sonoma is well-positioned to drive shareholder value in 2025 and 2026, with brand resilience and pricing power sustaining a robust capital return.
Via MarketBeat · August 27, 2025
Taylor Swift And Travis Kelce Are Engaged—And Polymarket Trader 'Romanticpaul' Predicted Itbenzinga.com
A Polymarket trader using the handle "romanticpaul" earned more than $3,000 in profits after correctly wagering on Taylor Swift's engagement to NFL star Travis Kelce just hours before the couple confirmed the news.
Via Benzinga · August 27, 2025
Pfizer, BioNTech Get FDA Clearance For Updated Covid Vaccine In Senior Adults And Younger At-Risk Populationstocktwits.com
Via Stocktwits · August 27, 2025
Krispy Kreme Slips After JPMorgan Downgrade, Cites ‘Survivor Mode’ Post McDonald’s Falloutstocktwits.com
Via Stocktwits · August 27, 2025
zSpace Empowers Educators with zKnow™: AI-Powered Assistant Delivers Instant Answers, Saving Teachers Valuable Timestocktwits.com
Via Stocktwits · August 27, 2025
Chinese Stocks Sink As Bubble Fears Revive Memories Of 2015 Crashbenzinga.com
US-listed Chinese stocks drop as investors worry about similarities to 2015 bubble. Alibaba's AI efforts struggle to generate revenue.
Via Benzinga · August 27, 2025
Summit, Akeso Report Lung Cancer Survival Boost With Ivonescimab, A Rival To Merck's Keytruda Multi-Billion Dollar Franchise, Says Analystbenzinga.com
Summit and Akeso report ivonescimab's survival benefit in lung cancer, boosting approval odds and positioning it as a Keytruda challenger.
Via Benzinga · August 27, 2025
Micron Stock Called 'Best Idea' Amid Business Transformationinvestors.com
Investment bank Baird has named Micron as one of its "Best Stock Ideas" ahead of the memory-chip maker's fiscal Q4 report.
Via Investor's Business Daily · August 27, 2025
Crude Oil Gains Over 1%; UP Fintech Shares Plungebenzinga.com
Via Benzinga · August 27, 2025
Google Cuts 35% Of Small-Team Managers In Efficiency Push: Reportstocktwits.com
Via Stocktwits · August 27, 2025
zSpace to Present at the 2025 Gateway Conference on September 4thstocktwits.com
Via Stocktwits · August 27, 2025
USD’s Optimistic Words – Implications For Goldcontent/com
It seems that all the negative surprises for the USD are already behind us, and that the sentiment for the USD hit the absolute worst.
Via Talk Markets · August 27, 2025
Unpacking the Latest Options Trading Trends in Carvanabenzinga.com
Via Benzinga · August 27, 2025
Institutions Hold $1.72 Billion In Solana, Strategic Reserve Data Revealsbenzinga.com
The Strategic SOL Reserve has released data showing that 13 entities, including public companies and corporate treasuries, collectively hold 8.277 million Solana (CRYPTO: SOL), equivalent to $1.72 billion at a current price of
Via Benzinga · August 27, 2025
Box Analysts Raise Their Forecasts After Strong Q2 Resultsbenzinga.com
Via Benzinga · August 27, 2025
CoreWeave Growth Fueled By OpenAI Contracts, Strategic Acquisition, Says Analystbenzinga.com
CoreWeave (NASDAQ: CRWV) shares rose as OpenAI contracts and a $9B Core Scientific deal boosted growth momentum.
Via Benzinga · August 27, 2025
Williams-Sonoma Raises Outlook on AIfool.com
Via The Motley Fool · August 27, 2025
America's Bankruptcy Wave Has Surpassed The Pandemic—And It's Getting Worsebenzinga.com
U.S. bankruptcies hit a post-2010 high as rates, tariffs, and AI squeeze small caps, iconic brands, and the labor market into economic retreat.
Via Benzinga · August 27, 2025
Abercrombie CFO Flags $90M Tariff Blow, Retail Still Bets Bigstocktwits.com
Via Stocktwits · August 27, 2025
What 7 Analyst Ratings Have To Say About Compassbenzinga.com
Via Benzinga · August 27, 2025
Looking Into MAG Silver's Recent Short Interestbenzinga.com
Via Benzinga · August 27, 2025
5 High-Flying Stocks Set For A Pullbackbenzinga.com
Via Benzinga · August 27, 2025
These Analysts Increase Their Forecasts On Ncino Following Better-Than-Expected Q2 Earningsbenzinga.com
Via Benzinga · August 27, 2025
XRP, Bitcoin Or ETH? Here's Which Coin Users Predict To Perform Best Until 2026benzinga.com
A poll questioning whether XRP (CRYPTO: XRP), Ethereum (CRYPTO: ETH) or Bitcoin (CRYPTO: BTC) will deliver the best return till the end of the
Via Benzinga · August 27, 2025
UP Fintech Shares Drop After Strong Q2 Results: What You Need To Knowbenzinga.com
UP Fintech Holding Limited (NASDAQ: TIGR) shares are trading lower Wednesday after the company released its second-quarter 2025 financial results.
Via Benzinga · August 27, 2025
RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.investors.com
Shares of one vaccine-maker are under pressure on Robert F. Kennedy Jr.'s move on Wednesday.
Via Investor's Business Daily · August 27, 2025
How Is The Market Feeling About Workday?benzinga.com
Via Benzinga · August 27, 2025
Analyst Expectations For Eli Lilly's Futurebenzinga.com
Via Benzinga · August 27, 2025
How Is The Market Feeling About Netflix?benzinga.com
Via Benzinga · August 27, 2025
Sharps Technology Soars After Insider Buys and $400M Solana Treasury Planbenzinga.com
Sharps Technology Inc. (NASDAQ: STSS) shares are trading higher Wednesday after two major announcements fueled investor enthusiasm.
Via Benzinga · August 27, 2025
Bank of Montreal Analysts Boost Their Forecasts After Q3 Resultsbenzinga.com
Via Benzinga · August 27, 2025
These Analysts Boost Their Forecasts On EchoStarbenzinga.com
Via Benzinga · August 27, 2025
Nano Nuclear Strikes Key Deal With Argentina's Only Uranium Feedstock Producerbenzinga.com
Nano Nuclear (NASDAQ: NNE) inked an MOU with Argentina's Dioxitek to explore uranium enrichment, strengthening its global nuclear fuel ambitions.
Via Benzinga · August 27, 2025
EUR/USD Eases Ahead Of U.S. Data But Risks Still Tilted To Upsidetalkmarkets.com
The EUR/USD remains neutral to somewhat positive amid an overall bearish dollar trend, with French political risks having limited immediate damage on the single currency.
Via Talk Markets · August 27, 2025
These Analysts Revise Their Forecasts On Okta After Upbeat Q2 Earningsbenzinga.com
Via Benzinga · August 27, 2025
P/E Ratio Insights for Bread Finl Hldgsbenzinga.com
Via Benzinga · August 27, 2025
Analyst Expectations For Essex Property Trust's Futurebenzinga.com
Via Benzinga · August 27, 2025
Global Trade on Edge: Escalating Tariffs Ignite Economic Uncertainty, Reshaping Supply Chains
The global economic landscape is increasingly shadowed by escalating trade tensions and policy uncertainties, particularly across the crucial US-China, US-India, and EU-China corridors. A complex web of new tariffs and retaliatory measures is reshaping international commerce, pushing global supply chains to their breaking point, squeezing corporate earnings, and fueling widespread
Via MarketMinute · August 27, 2025
Better Media Stock: Newsmax vs. The New York Timesfool.com
Two media companies, two business models, one clear winner. Let's follow the money instead of the politics.
Via The Motley Fool · August 27, 2025
MongoDB To Rally Around 63%? Here Are 10 Top Analyst Forecasts For Wednesdaybenzinga.com
Via Benzinga · August 27, 2025
What's going on in today's session: S&P500 most active stockschartmill.com
Stay informed about the most active stocks in the S&P500 index on Wednesday's session. Discover the stocks that are generating the highest trading volume and driving market activity.
Via Chartmill · August 27, 2025
Decoding Bank of America's Options Activity: What's the Big Picture?benzinga.com
Via Benzinga · August 27, 2025
Forecasting The Future: 8 Analyst Projections For Synopsysbenzinga.com
Via Benzinga · August 27, 2025
CrowdStrike Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Callbenzinga.com
Via Benzinga · August 27, 2025
5 Analysts Assess Lineage Cell Therapeutics: What You Need To Knowbenzinga.com
Via Benzinga · August 27, 2025
Analyst Expectations For Omega Healthcare Invts's Futurebenzinga.com
Via Benzinga · August 27, 2025
These stocks are making the most noise in today's session.chartmill.com
Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action!
Via Chartmill · August 27, 2025